New strategy to improve quality control of Montenegro skin test at the production level

The production of the Montenegro antigen for skin test poses difficulties regarding quality control. Here, we propose that certain animal models reproducing a similar immune response to humans may be used in the quality control of Montenegro antigen production. Fifteen Cavia porcellus (guinea pigs)...

Full description

Saved in:
Bibliographic Details
Published inRevista da Sociedade Brasileira de Medicina Tropical Vol. 50; no. 6; pp. 788 - 794
Main Authors Guedes, Deborah Carbonera, Minozzo, João Carlos, Pasquali, Aline Kuhn Sbruzzi, Faulds, Craig, Soccol, Carlos Ricardo, Thomaz-Soccol, Vanete
Format Journal Article
LanguageEnglish
Published Brazil Sociedade Brasileira de Medicina Tropical 01.11.2017
Sociedade Brasileira de Medicina Tropical - SBMT
Sociedade Brasileira de Medicina Tropical (SBMT)
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The production of the Montenegro antigen for skin test poses difficulties regarding quality control. Here, we propose that certain animal models reproducing a similar immune response to humans may be used in the quality control of Montenegro antigen production. Fifteen Cavia porcellus (guinea pigs) were immunized with Leishmania amazonensis or Leishmania braziliensis , and, after 30 days, they were skin tested with standard Montenegro antigen. To validate C. porcellus as an animal model for skin tests, eighteen Mesocricetus auratus (hamsters) were infected with L. amazonensis or L. braziliensis , and, after 45 days, they were skin tested with standard Montenegro antigen. Cavia porcellus immunized with L. amazonensis or L. braziliensis , and hamsters infected with the same species presented induration reactions when skin tested with standard Montenegro antigen 48-72h after the test. The comparison between immunization methods and immune response from the two animal species validated C. porcellus as a good model for Montenegro skin test, and the model showed strong potential as an in vivo model in the quality control of the production of Montenegro antigen.
ISSN:0037-8682
1678-9849
1678-9849
DOI:10.1590/0037-8682-0131-2017